{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:26:58Z","timestamp":1781526418867,"version":"3.54.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":1331,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Approximately two-thirds of new cases of tuberculosis (TB) in the United States are among non\u2013U.S.-born persons. Culture-based overseas TB screening in U.S.-bound immigrants and refugees has substantially reduced the importation of TB into the United States, but it is unclear to what extent this program prevents the importation of multidrug-resistant TB (MDR-TB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To study the epidemiology of MDR-TB in U.S.-bound immigrants and refugees and to evaluate the effect of culture-based overseas TB screening in U.S.-bound immigrants and refugees on reducing the importation of MDR-TB into the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data of immigrants and refugees who completed overseas treatment for culture-positive TB during 2015\u20132019. We also compared mean annual number of MDR-TB cases in non\u2013U.S.-born persons within 1 year of arrival in the United States between 1996\u20132006 (when overseas screening followed a smear-based algorithm) and 2014\u20132019 (after full implementation of a culture-based algorithm).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 3,300 culture-positive TB cases identified by culture-based overseas TB screening in immigrants and refugees during 2015\u20132019, 122 (3.7%; 95% confidence interval [CI], 3.1\u20134.1) had MDR-TB, 20 (0.6%; 95% CI, 0.3\u20130.9) had rifampicin-resistant TB, 382 (11.6%; 95% CI, 10.5\u201312.7) had isoniazid-resistant TB, and 2,776 (84.1%; 95% CI, 82.9\u201385.4) had rifampicin- and isoniazid-susceptible TB. None were diagnosed with extensively drug-resistant TB. All 3,300 persons with culture-positive TB completed treatment overseas; of 70 and 11 persons who were treated overseas for MDR-TB and rifampicin-resistant TB, respectively, none were diagnosed with TB disease at postarrival evaluation in the United States. Culture-based overseas TB screening in U.S.-bound immigrants and refugees prevented 24.4 MDR-TB cases per year from arriving in the United States, 18.2 cases more than smear-based overseas TB screening. The mean annual number of MDR-TB cases among non\u2013U.S.-born persons within 1 year of arrival in the United States decreased from 34.6 cases in 1996\u20132006 to 19.5 cases in 2014\u20132019 (difference of 15.1; P\u2009&amp;lt;\u20090.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Culture-based overseas TB screening in U.S.-bound immigrants and refugees substantially reduced the importation of MDR-TB into the United States.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202105-580oc","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T13:12:29Z","timestamp":1640265149000},"page":"943-951","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":9,"title":["Multidrug-Resistant Tuberculosis in U.S.-Bound Immigrants and Refugees"],"prefix":"10.1093","volume":"19","author":[{"given":"Yecai","family":"Liu","sequence":"first","affiliation":[{"name":"Division of Global Migration and Quarantine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew L.","family":"Posey","sequence":"additional","affiliation":[{"name":"Division of Global Migration and Quarantine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanhe","family":"Yang","sequence":"additional","affiliation":[{"name":"Division for Heart Disease and Stroke Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Division of Global Migration and Quarantine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Maloney","sequence":"additional","affiliation":[{"name":"Division of Global HIV and TB, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Lambert","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis S.","family":"Ortega","sequence":"additional","affiliation":[{"name":"Division of Global Migration and Quarantine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Marano","sequence":"additional","affiliation":[{"name":"Division of Global Migration and Quarantine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Cetron","sequence":"additional","affiliation":[{"name":"Division of Global Migration and Quarantine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R.","family":"Phares","sequence":"additional","affiliation":[{"name":"Division of Global Migration and Quarantine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"2026012203323844300_bib1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMra0908076","article-title":"MDR tuberculosis--critical steps for prevention and control","volume":"363","author":"Nathanson","year":"2010","journal-title":"N Engl J Med"},{"key":"2026012203323844300_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1586\/14787210.5.5.857","article-title":"Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control","volume":"5","author":"Matteelli","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026012203323844300_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ccm.2009.08.015","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control","volume":"30","author":"Migliori","year":"2009","journal-title":"Clin Chest Med"},{"key":"2026012203323844300_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ccm.2009.08.019","article-title":"Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children","volume":"30","author":"Schaaf","year":"2009","journal-title":"Clin Chest Med"},{"key":"2026012203323844300_bib5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(15)00458-0","article-title":"Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis","volume":"3","author":"Kendall","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2026012203323844300_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa1604544","article-title":"Transmission of extensively drug-resistant tuberculosis in South Africa","volume":"376","author":"Shah","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012203323844300_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cmi.2016.09.009","article-title":"Multidrug-resistant tuberculosis and migration to Europe","volume":"23","author":"Hargreaves","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2026012203323844300_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1473-3099(17)30247-5","article-title":"Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study","volume":"17","author":"Sharma","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2026012203323844300_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.15585\/mmwr.mm6811a3","article-title":"Global epidemiology of tuberculosis and progress toward achieving global target \u2013 2017","volume":"68","author":"MacNeil","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026012203323844300_bib10","author":"World Health Organization","year":"2019"},{"key":"2026012203323844300_bib11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.idc.2019.09.002","article-title":"Multidrug and extensively drug-resistant tuberculosis. Epidemiology, clinical features, management and treatment","volume":"33","author":"Tiberi","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"2026012203323844300_bib12","doi-asserted-by":"crossref","first-page":"18099","DOI":"10.1038\/s41598-019-54561-9","article-title":"Projecting the impact of variable MDR-TB transmission efficiency on long-term epidemic trends in South Africa and Vietnam","volume":"9","author":"Salvatore","year":"2019","journal-title":"Sci Rep"},{"key":"2026012203323844300_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.15585\/mmwr.mm6911a3","article-title":"Tuberculosis - United States, 2019","volume":"69","author":"Schwartz","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026012203323844300_bib14","author":"Centers for Disease Control and Prevention"},{"key":"2026012203323844300_bib15","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"2026012203323844300_bib16","author":"Centers for Disease Control and Prevention"},{"key":"2026012203323844300_bib17","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/clinids\/23.6.1226","article-title":"Overseas screening for tuberculosis in immigrants and refugees to the United States: current status","volume":"23","author":"Binkin","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2026012203323844300_bib18","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa0809497","article-title":"Overseas screening for tuberculosis in U.S.-bound immigrants and refugees","volume":"360","author":"Liu","year":"2009","journal-title":"N Engl J Med"},{"key":"2026012203323844300_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7326\/M14-2082","article-title":"Effect of a culture-based screening algorithm on tuberculosis incidence in immigrants and refugees bound for the United States: a population-based cross-sectional study","volume":"162","author":"Liu","year":"2015","journal-title":"Ann Intern Med"},{"key":"2026012203323844300_bib20","first-page":"1171","author":"Liu","year":"2012"},{"key":"2026012203323844300_bib21","author":"Centers for Disease Control and Prevention"},{"key":"2026012203323844300_bib22","first-page":"1","article-title":"Disease surveillance among newly arriving refugees and immigrants--Electronic Disease Notification System, United States, 2009","volume":"62","author":"Lee","year":"2013","journal-title":"MMWR Surveill Summ"},{"key":"2026012203323844300_bib23","author":"Centers for Disease Control and Prevention"},{"key":"2026012203323844300_bib24","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1513\/AnnalsATS.201908-623OC","article-title":"Tuberculosis among newly arrived immigrants and refugees in the United States","volume":"17","author":"Liu","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203323844300_bib25","doi-asserted-by":"crossref","first-page":"e0147353","DOI":"10.1371\/journal.pone.0147353","article-title":"Abrupt decline in tuberculosis among foreign-born persons in the United States","volume":"11","author":"Baker","year":"2016","journal-title":"PLoS One"},{"key":"2026012203323844300_bib26","doi-asserted-by":"crossref","first-page":"1240e9","DOI":"10.1016\/S1473-3099(14)70966-1","article-title":"Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis","volume":"14","author":"Aldridge","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2026012203323844300_bib27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.5694\/mja11.11395","article-title":"Is premigration health screening for tuberculosis worthwhile?","volume":"195","author":"King","year":"2011","journal-title":"Med J Aust"},{"key":"2026012203323844300_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archinte.166.2.234","article-title":"Assessing the performance of overseas tuberculosis screening programs: a study among U.S.-bound immigrants in Vietnam","volume":"166","author":"Maloney","year":"2006","journal-title":"Arch Intern Med"},{"key":"2026012203323844300_bib29","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3201\/eid1411.071629","article-title":"Multidrug-resistant tuberculosis outbreak among U.S.-bound Hmong refugees, Thailand, 2005","volume":"14","author":"Oeltmann","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"2026012203323844300_bib30","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/S0140-6736(16)31008-X","article-title":"Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519\u2008955 migrants screened before entry to England, Wales, and Northern Ireland","volume":"388","author":"Aldridge","year":"2016","journal-title":"Lancet"},{"key":"2026012203323844300_bib31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1473-3099(16)00072-4","article-title":"Prevalence of and risk factors for active tuberculosis in migrants screened before entry to the UK: a population-based cross-sectional study","volume":"16","author":"Aldridge","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2026012203323844300_bib32","first-page":"100135","article-title":"Tuberculosis in migrants to Australia: Outcomes of a national screening program","volume":"10","author":"Trauer","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"2026012203323844300_bib33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.5588\/ijtld.14.0785","article-title":"The fourth national anti-tuberculosis drug resistance survey in Viet Nam","volume":"19","author":"Nhung","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026012203323844300_bib34","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","article-title":"National survey of drug-resistant tuberculosis in China","volume":"366","author":"Zhao","year":"2012","journal-title":"N Engl J Med"},{"key":"2026012203323844300_bib35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1473-3099(13)70128-2","article-title":"Transmission of multidrug-resistant tuberculosis in the U.S.A: a cross-sectional study","volume":"13","author":"Moonan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2026012203323844300_bib36","author":"U.S. Department of Homeland Security, Office of Immigration Statistics","year":"2019"},{"key":"2026012203323844300_bib37","doi-asserted-by":"crossref","first-page":"e32158","DOI":"10.1371\/journal.pone.0032158","article-title":"Estimating the impact of newly arrived foreign-born persons on tuberculosis in the United States","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"2026012203323844300_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study","volume":"18","author":"Dorman","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2026012203323844300_bib39","author":"World Health Organization"},{"key":"2026012203323844300_bib40","author":"U.S. Office of Immigration Statistics"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/6\/943\/66331421\/annalsats_19_6_943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/6\/943\/66331421\/annalsats_19_6_943.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:35:40Z","timestamp":1769070940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/19\/6\/943\/8418899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202105-580oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6]]},"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"2021-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}